Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10013)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 28, 2015 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Slotta JE, Kollmar O, Ellenrieder V, Ghadimi BM, Homayounfar K. Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives. World J Hepatol 2015; 7(9): 1168-1183 [PMID: 26019733 DOI: 10.4254/wjh.v7.i9.1168] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i9/1168.htm |
| Number | Citing Articles |
| 1 |
Jendrik Becker-Assmann, Mohammad H. Fard-Aghaie, Alexandros Kantas, Georgios Makridis, Tim Reese, Kim C. Wagner, Jörg Petersen, Peter Buggisch, Axel Stang, Thomas von Hahn, Karl J. Oldhafer. Diagnostische und prognostische Bedeutung des α-Feto-Proteins beim hepatozellulären Karzinom. Der Chirurg 2020; 91(9): 769 doi: 10.1007/s00104-020-01118-6
|
| 2 |
Mattia Garancini, Enrico Pinotti, Stefano Nespoli, Fabrizio Romano, Luca Gianotti, Vittorio Giardini. Hepatic resection beyond barcelona clinic liver cancer indication: When and how. World Journal of Hepatology 2016; 8(11): 513-519 doi: 10.4254/wjh.v8.i11.513
|
| 3 |
ZHICHENG YAO, KUNPENG HU, HE HUANG, SHILEI XU, QINGLIANG WANG, PENG ZHANG, PEISHENG YANG, BO LIU. shRNA-mediated silencing of the RFC3 gene suppresses hepatocellular carcinoma cell proliferation. International Journal of Molecular Medicine 2015; 36(5): 1393 doi: 10.3892/ijmm.2015.2350
|
| 4 |
Shengyan Xi, Ying Peng, Gerald Y. Minuk, Mengmeng Shi, Biqian Fu, Jiaqi Yang, Qian Li, Yuewen Gong, Lifeng Yue, Lili Li, Jinhua Guo, Yang Peng, Yanhui Wang. The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy. Journal of Ethnopharmacology 2016; 190: 1 doi: 10.1016/j.jep.2016.05.055
|
| 5 |
Antonio Giorgio, Maria G Merola, Luca Montesarchio, Francesca Merola, Pietro Gatti, Carmine Coppola, Valentina Giorgio, Giorgio Calisti. Percutaneous radiofrequency ablation of hepatocellular carcinoma in cirrhosis: analysis of complications in a single centre over 20 years. The British Journal of Radiology 2017; 90(1074): 20160804 doi: 10.1259/bjr.20160804
|
| 6 |
Leonardo Lorente, Sergio T Rodriguez, Pablo Sanz, Agustín F González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel A Barrera. Patients with hepatocellular carcinoma that die during the first year of liver transplantation have high blood sFasL concentrations . World Journal of Clinical Cases 2023; 11(8): 1753-1760 doi: 10.12998/wjcc.v11.i8.1753
Abstract(510) |
Core Tip(377) |
Full Article(HTML)(1176)
|
Full Article (PDF)-1008K(125)
|
Full Article (Word)-308K(38)
|
Audio-126K(5)
|
Peer-Review Report-459K(51)
|
Answering Reviewers-161K(55)
|
Times Cited (0)
|
Total Visits (4604)
|
Open
|
| 7 |
A. Bauschke, A. Altendorf-Hofmann, C. Malessa, S. Schüle, J. Zanow, U. Settmacher. Which factors affect the long-term survival of patients with hepatocellular carcinoma UICC stage IV?. Journal of Cancer Research and Clinical Oncology 2016; 142(12): 2593 doi: 10.1007/s00432-016-2260-y
|
| 8 |
Michihiro Kudou, Atsushi Shiozaki, Toshiyuki Kosuga, Hiroki Shimizu, Daisuke Ichikawa, Hirotaka Konishi, Ryo Morimura, Shuhei Komatsu, Hisashi Ikoma, Hitoshi Fujiwara, Kazuma Okamoto, Yoshinori Marunaka, Eigo Otsuji. Heat shock exerts anticancer effects on liver cancer via autophagic degradation of aquaporin 5. International Journal of Oncology 2017; 50(5): 1857 doi: 10.3892/ijo.2017.3940
|
| 9 |
Zuzanna Sas, Ewa Cendrowicz, Isabel Weinhäuser, Tomasz P. Rygiel. Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options. International Journal of Molecular Sciences 2022; 23(7): 3778 doi: 10.3390/ijms23073778
|
| 10 |
Teodora Surdea-Blaga, Roxana L. Cărăguț, Cosmin Caraiani, Zeno Spârchez, Nadim al Hajjar, Dan L. Dumitrașcu. Overlap syndrome of autoimmune hepatitis and primary biliary cholangitis complicated with atypical hepatocellular carcinoma: a case report. Journal of Medical Case Reports 2023; 17(1) doi: 10.1186/s13256-023-03932-y
|
| 11 |
Hyosun Tak, Hoin Kang, Eunbyul Ji, Youlim Hong, Wook Kim, Eun Kyung Lee. Potential use of TIA-1, MFF, microRNA-200a-3p, and microRNA-27 as a novel marker for hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2018; 497(4): 1117 doi: 10.1016/j.bbrc.2018.02.189
|
| 12 |
Zaixiong Ji, Jiaqi Li, Jianbo Wang. Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma. Hereditas 2021; 158(1) doi: 10.1186/s41065-021-00179-9
|
| 13 |
Jingyao Hu, Liang Yang, Xueqiang Peng, Minghuan Mao, Xiaodan Liu, Jianbo Song, Hangyu Li, Fu Chen. METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma. Human Cell 2022; 35(6): 1838 doi: 10.1007/s13577-022-00769-3
|
| 14 |
Yanxia Gong, Jie Zhang, Xiang Wu, Tao Wang, Jia Zhao, Zhi Yao, Qingyu Zhang, Xi Liu, Xu Jian. Specific expression of proton-coupled oligopeptide transporter 1 in primary hepatocarcinoma-a novel strategy for tumor-targeted therapy. Oncology Letters 2017; 14(4): 4158 doi: 10.3892/ol.2017.6724
|
| 15 |
Leonardo Lorente. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(37): 4230-4242 doi: 10.3748/wjg.v24.i37.4230
|
| 16 |
Ningning Liu, Xiaomei Wang, Clifford John Steer, Guisheng Song. MicroRNA-206 promotes the recruitment of CD8+ T cells by driving M1 polarisation of Kupffer cells. Gut 2021; : gutjnl-2021-324170 doi: 10.1136/gutjnl-2021-324170
|
| 17 |
Junjie Hu, Ningning Liu, David Song, Clifford J. Steer, Guohua Zheng, Guisheng Song. A positive feedback between cholesterol synthesis and the pentose phosphate pathway rather than glycolysis promotes hepatocellular carcinoma. Oncogene 2023; 42(39): 2892 doi: 10.1038/s41388-023-02757-9
|
| 18 |
Ningning Liu, Ching Wen Chang, Clifford J. Steer, Xin Wei Wang, Guisheng Song. MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication Between Kupffer Cells and Regulatory T Cells. Gastroenterology 2022; 162(2): 575 doi: 10.1053/j.gastro.2021.10.015
|
| 19 |
Tonghai Xing, Tingmang Yan, Qiang Zhou. Identification of key candidate genes and pathways in hepatocellular carcinoma by integrated bioinformatical analysis. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6075
|
| 20 |
Sebastian Lünse, Claus-Dieter Heidecke, Lars Ivo Partecke. Hepatocellular Carcinoma. 2019; : 111 doi: 10.15586/hepatocellularcarcinoma.2019.ch6
|
| 21 |
Xiao-Bo Lai, Yu-Qiang Nie, Hong-Li Huang, Ying-Fei Li, Chuang-Yu Cao, Hui Yang, Bo Shen, Zhi-Qiang Feng. NIMA-related kinase 2 regulates hepatocellular carcinoma cell growth and proliferation. Oncology Letters 2017; 13(3): 1587 doi: 10.3892/ol.2017.5618
|
| 22 |
Heng Wu, Junyan Tao, Xiaolei Li, Tianpeng Zhang, Lei Zhao, Yao Wang, Lei Zhang, Jun Xiong, Zhi Zeng, Na Zhan, Clifford J. Steer, Li Che, Mingjie Dong, Xiaomei Wang, Junqi Niu, Zhuoyu Li, Guiqing Yan, Xin Chen, Guisheng Song. MicroRNA‐206 prevents the pathogenesis of hepatocellular carcinoma by modulating expression of met proto‐oncogene and cyclin‐dependent kinase 6 in mice. Hepatology 2017; 66(6): 1952 doi: 10.1002/hep.29374
|
| 23 |
Bashan Zhang, Fei Li, Zinian Zhu, Aijiao Ding, Jintong Luo. <p>CircRNA CDR1as/miR-1287/Raf1 Axis Modulates Hepatocellular Carcinoma Progression Through MEK/ERK Pathway</p>. Cancer Management and Research 2020; : 8951 doi: 10.2147/CMAR.S252679
|
| 24 |
Leonardo Lorente, Sergio T. Rodriguez, Pablo Sanz, Agustín F. González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M. Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel A. Barrera. High serum caspase-3 levels in hepatocellular carcinoma prior to liver transplantation and high mortality risk during the first year after liver transplantation. Expert Review of Molecular Diagnostics 2019; 19(7): 635 doi: 10.1080/14737159.2019.1619549
|
| 25 |
Leonardo Lorente, Sergio T Rodriguez, Pablo Sanz, Agustín F González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel A Barrera. DNA and RNA oxidative damage in hepatocellular carcinoma patients and mortality during the first year of liver transplantation. World Journal of Hepatology 2022; 14(6): 1182-1189 doi: 10.4254/wjh.v14.i6.1182
|
| 26 |
Dalia A. Gaber, Olfat Shaker, Alaa Tarek Younis, Mohamed El-Kassas. LncRNA HULC and miR-122 Expression Pattern in HCC-Related HCV Egyptian Patients. Genes 2022; 13(9): 1669 doi: 10.3390/genes13091669
|
| 27 |
Xinyan Chen, Xianxian Hu, Junjie Hu, Zhenpeng Qiu, Ming Yuan, Guohua Zheng. Celastrol-Loaded Galactosylated Liposomes Effectively Inhibit AKT/c-Met-Triggered Rapid Hepatocarcinogenesis in Mice. Molecular Pharmaceutics 2020; 17(3): 738 doi: 10.1021/acs.molpharmaceut.9b00428
|
| 28 |
Sidra Altaf, Faiza Saleem, Azam Ali Sher, Ashiq Ali. Potential Therapeutic Strategies to Combat HCC. Current Molecular Pharmacology 2022; 15(7): 929 doi: 10.2174/1874467215666220103111009
|
| 29 |
Eman K. A. Abdelall, Heba A. H. Elshemy, Madlen B. Labib, Fatma E. A. Mohamed. Design, synthesis of novel chromene‐based scaffolds targeting hepatocellular carcinoma: Cell cycle arrest, cytotoxic effect against resistant cancer cells, apoptosis induction, and c‐Src inhibition. Drug Development Research 2024; 85(1) doi: 10.1002/ddr.22133
|
| 30 |
Leonardo Lorente, Sergio Rodriguez, Pablo Sanz, Pedro Abreu-González, Dácil Díaz, Antonia Moreno, Elisa Borja, María Martín, Alejandro Jiménez, Manuel Barrera. Association between Pre-Transplant Serum Malondialdehyde Levels and Survival One Year after Liver Transplantation for Hepatocellular Carcinoma. International Journal of Molecular Sciences 2016; 17(4): 500 doi: 10.3390/ijms17040500
|
| 31 |
Daoyan Wei, Dongmei Chen, Hongyuan Mou, Sharmistha Chakraborty, Bo Wei, Lin Tan, Philip L. Lorenzi, Xiangping Qian, Peiying Yang. Targeting Glutamine Metabolism with a Novel Na+/K+-ATPase Inhibitor RX108 in Hepatocellular Carcinoma. Molecular Cancer Therapeutics 2023; 22(6): 693 doi: 10.1158/1535-7163.MCT-22-0490
|
| 32 |
Jixiong Hu, Weidong Dai, Chun Liu, Tenglong Tang. Atlas of Anatomic Hepatic Resection for Hepatocellular Carcinoma. 2019; : 261 doi: 10.1007/978-981-13-0668-6_5
|
| 33 |
Leonardo Lorente, Sergio T. Rodriguez, Pablo Sanz, Pedro Abreu-González, Agustín F. González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M. Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel A. Barrera. Low Serum Melatonin Levels Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma are Associated with Lower Survival after Liver Transplantation. International Journal of Molecular Sciences 2019; 20(7): 1696 doi: 10.3390/ijms20071696
|
| 34 |
Ashwaq Alolyan, Kanan Alshammari, Mohammad Arabi, Ahmed Alshehri, Hamad Alsuhaibani, Fahad Ibnshamsah, Abdullah Alsharm, Mervat Mahrous, Adnan Al Zanbagi, Mazen Hassanain, Shouki Bazarbashi. Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia. Journal of Hepatocellular Carcinoma 2024; : 349 doi: 10.2147/JHC.S442842
|
| 35 |
Hengjing He, Muhammad Jamal, Xingruo Zeng, Yufei Lei, Di Xiao, Zimeng Wei, Chengjie Zhang, Xiaoyu Zhang, Shan Pan, Qianshan Ding, Haiyan Tan, Songping Xie, Qiuping Zhang. Matrin-3 acts as a potential biomarker and promotes hepatocellular carcinoma progression by interacting with cell cycle-regulating genes. Cell Cycle 2024; 23(1): 15 doi: 10.1080/15384101.2024.2305535
|
| 36 |
Jian-Jun Gao, Zhen-Yan Shi, Ju-Feng Xia, Yoshinori Inagaki, Wei Tang. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12059-12070 doi: 10.3748/wjg.v21.i42.12059
|
| 37 |
Jasem Albarrak, Humaid Al-Shamsi. Current Status of Management of Hepatocellular Carcinoma in The Gulf Region: Challenges and Recommendations. Cancers 2023; 15(7): 2001 doi: 10.3390/cancers15072001
|